Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) PE Ratio (TTM): 7.41 (As of Jul. 12, 2026) — 52% Below Median


FRA:GU5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd FRA:GU5
68 GF Score
Price €1.66
GF Value €2.39
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co PE Ratio (TTM)?

Guangzhou Baiyunshan Pharmaceutical Holdings Co FRA:GU5 -0.60% 68 PE Ratio (TTM) is 7.41 as of Jul. 12, 2026, which is 52% below its 10-year median of 15.40. GuruFocus rates FRA:GU5 with a GF Score™ of 68/100 and a GF Value™ of €2.39 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 87 Medical Distribution companies, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks better than 65.52% on this metric.

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-12), Guangzhou Baiyunshan Pharmaceutical Holdings Co's share price is €1.66. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.22. Therefore, Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) for today is 7.41.

Good Sign:

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock PE Ratio (=11.75) is close to 1-year low of 10.91.


The historical rank and industry rank for Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) or its related term are showing as below:

FRA:GU5' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 10.54   Med: 15.4   Max: 28.01
Current: 11.75


During the past 13 years, the highest PE Ratio (TTM) of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 28.01. The lowest was 10.54. And the median was 15.40.


FRA:GU5's PE Ratio (TTM) is ranked better than
65.52% of 87 companies
in the Medical Distribution industry
Industry Median: 15.5 vs FRA:GU5: 11.75

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was €0.14. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.22.

As of today (2026-07-12), Guangzhou Baiyunshan Pharmaceutical Holdings Co's share price is €1.66. Guangzhou Baiyunshan Pharmaceutical Holdings Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was €0.24. Therefore, Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio without NRI for today is 7.00.

During the past 13 years, Guangzhou Baiyunshan Pharmaceutical Holdings Co's highest PE Ratio without NRI was 27.74. The lowest was 10.30. And the median was 15.06.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's EPS without NRI for the three months ended in Mar. 2026 was €0.14. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was €0.24.

During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average EPS without NRI Growth Rate was 11.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was -10.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was -4.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.20% per year.

During the past 13 years, Guangzhou Baiyunshan Pharmaceutical Holdings Co's highest 3-Year average EPS without NRI Growth Rate was 85.60% per year. The lowest was -27.70% per year. And the median was 10.70% per year.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's EPS (Basic) for the three months ended in Mar. 2026 was €0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.22.


Guangzhou Baiyunshan Pharmaceutical Holdings Co  (FRA:GU5) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Guangzhou Baiyunshan Pharmaceutical Holdings Co PE Ratio (TTM) Related Terms


Guangzhou Baiyunshan Pharmaceutical Holdings Co PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co PE Ratio (TTM) Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.95 12.21 11.46 16.30 14.03

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.94 15.29 13.91 14.03 12.62

FRA:GU5 vs MCK, CAH, COR: PE Ratio (TTM) Comparison

For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co PE Ratio (TTM) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) falls into.


FRA:GU5
68GF Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd FRA:GU5
PE Ratio (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Baiyunshan Pharmaceutical Holdings Co PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=1.66/0.224
=7.41

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Share Price of today is €1.66.
Guangzhou Baiyunshan Pharmaceutical Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio (TTM) →
What does a PE Ratio (TTM) of 7.41 mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) has a PE Ratio (TTM) of 7.41 as of Jul. 12, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. This is 52% below median its historical median of 15.40. Over the past decade, Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) has ranged from 10.54 to 28.01. According to the industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #30 out of 87 companies in the Medical Distribution industry, placing it in the top 34.5%.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current PE Ratio (TTM) of 7.41 is 52% below median its 10-year median of 15.40. Over the past 10 years, this metric has ranged from a low of 10.54 to a high of 28.01. The Medical Distribution industry median PE Ratio (TTM) is 15.50. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 7.41 is 52.2% below this industry median. Based on the distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #30 out of 87 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's PE Ratio (TTM) compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #30 out of 87 companies for PE Ratio (TTM). This puts Guangzhou Baiyunshan Pharmaceutical Holdings Co in the upper half of its industry. The industry median PE Ratio (TTM) is 15.50. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 7.41 is 52.2% below this benchmark. Historically, Guangzhou Baiyunshan Pharmaceutical Holdings Co's own PE Ratio (TTM) has ranged from 10.54 to 28.01 over the past decade. While the company's 10-year median is 15.40 vs. the industry median of 15.50, Guangzhou Baiyunshan Pharmaceutical Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Distribution company?
The median PE Ratio (TTM) among Medical Distribution companies is 15.50, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current PE Ratio (TTM) of 7.41 is 52.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. For the Medical Distribution industry, the median PE Ratio (TTM) is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current PE Ratio (TTM) is 7.41, which is 52% below median its own 10-year median of 15.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.39, compared to a current price of €1.66 — trading 30.5% below its estimated fair value. The current PE Ratio (TTM) is 7.41, which is 52% below median its 10-year median of 15.40 and 52.2% below the Medical Distribution industry median of 15.50. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5), the current PE Ratio (TTM) is 7.41 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of €1.66 is trading 30.5% below its estimated GF Value™ of €2.39. GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Significantly Undervalued.

Key valuation signals for FRA:GU5:

  • PE Ratio (TTM): 7.41 (52% below median its 10-year median of 15.40)
  • GF Value™: €2.39 vs. price of €1.66 (30.5% below fair value)
  • GF Score™: 68/100 with 6 warning signs
  • Industry Position: 52.2% below the Medical Distribution median (#30 of 87)

No single metric tells the full story. See the FRA:GU5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Other Exchanges 00874:Hong Kong600332:China
Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
68GF Score

Get the complete analysis for FRA:GU5

PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.66
Price
€2.39
GF Value